Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Kenvue Inc.KVUE · Entity 3098 | Director | May 21, 2026 | May 26, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Kenvue Inc.
Report date May 21, 2026 · Filed May 26, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Deferred Share UnitsSEC Table II · derivative / convertible security | Direct | 56,975.45 |
Reported balance
After 2026-05-21 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-05-21 · Grant · Acquired 16,036 · Balance 56,975.45 F1: Grant of Deferred Share Units ("DSUs") under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date). F2: Includes DSUs acquired as dividend equivalents. |
Filing footnotes · ownership attribution and instrument terms
F1: Grant of Deferred Share Units ("DSUs") under the Issuer's Amended and Restated Deferred Fee Plan for Directors are to be settled in shares of the Issuer's common stock upon termination of the Reporting Person's directorship (with each DSU representing the right to receive one share of Common Stock on the settlement date).
F2: Includes DSUs acquired as dividend equivalents.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
CVS HEALTH Corp
Report date May 31, 2021 · Filed June 02, 2021
Section 16 reporting ended · disclosed 2021-06-02. Current position is not established by this disclosure.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 632,312.9407 |
Reported balance
After 2021-05-31 transaction · row 1
1 source rowRow 1 · 2021-05-31 · Tax withholding · Disposed 634 · Balance 632,312.9407 F1: Surrender of shares in payment of FICA taxes due upon retirement. |
Filing footnotes · ownership attribution and instrument terms
F1: Surrender of shares in payment of FICA taxes due upon retirement.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| April 02, 2007 Filed Apr 4, 2007 21:24 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 13,174 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000079 · doc.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,367 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| April 02, 2007 Filed Apr 18, 2007 20:19 UTC Amendment | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 13,074 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000089 · doc.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 134,267 F1 · shares: Consists of Restricted Stock Units awarded pursuant to issuer's 1997 Incentive Compensation Plan. Restrictions lapse in two equal installments on 4/2/2010 and 4/2/2012. F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| February 12, 2007 Filed Feb 20, 2007 18:42 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 9,436 | $0.00 | $0.00 |
DisclosureSEC source: 0000064803-07-000032 · doc.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,110 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receipt of which the reporting person has elected to defer. Read SEC document |
| January 03, 2007 Filed Jan 5, 2007 21:31 UTC | CVS HEALTH Corp CVS · Entity 2884 | Tax withholdingCommon Stock | 9,515 | $30.93 | $294,251.38 |
DisclosureSEC source: 0000064803-07-000001 · doc.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust as Beneficiary Disclosed balance after: 314,797 F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 200,920 | $0.00 Strike: $11.50 | $0.00 |
DisclosureSEC source: 0000064803-06-000044 · doc.xml · derivative · entry 4 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 200,920 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: Option became exercisable in three equal annual installments, commencing 02/17/00. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 131,486 | $29.76 | $3,912,720.94 |
DisclosureSEC source: 0000064803-06-000044 · doc.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,954 F2 · kind: The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| December 06, 2006 Filed Dec 7, 2006 21:30 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 200,920 | $11.50 | $2,310,580.00 |
DisclosureSEC source: 0000064803-06-000044 · doc.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 232,440 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| April 03, 2006 Filed Apr 5, 2006 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 161,359 | $0.00 Strike: $30.04 | $0.00 |
DisclosureSEC source: 0001194405-06-000011 · doc.xml · derivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 161,359 Underlying: Common Stock · 161,359 shares Expires 2013-04-03 F1 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 4/3/07 Read SEC document |
| April 03, 2006 Filed Apr 5, 2006 20:21 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 14,566 | $0.00 | $0.00 |
DisclosureSEC source: 0001194405-06-000011 · doc.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 74,566 Read SEC document |
| February 16, 2006 Filed Feb 21, 2006 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Unit | 10,700 | $0.00 | $0.00 |
DisclosureSEC source: 0001194405-06-000003 · doc.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,700 F2 · shares: Consists of Stock Units awarded at market price pursuant to Issuer's 1997 Incentive Compensation Plan, the receirpt of which the reporting person has elected to defer. Read SEC document |
| March 10, 2005 Filed Mar 10, 2005 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 83,702 | $52.62 | $4,404,231.84 |
DisclosureSEC source: 0001194413-05-000002 · c0001194413d20050310f4f.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,749 F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 30,000 | $0.00 Strike: $23.00 | $0.00 |
DisclosureSEC source: 0001194413-05-000002 · c0001194413d20050310f4f.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,460 Underlying: Common Stock · 30,000 shares Expires 2007-02-17 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Cash exercise funded by Insider. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 53,702 | $0.00 Strike: $16.72 | $0.00 |
DisclosureSEC source: 0001194413-05-000002 · c0001194413d20050310f4f.xml · derivative · entry 5 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 53,702 shares Expires 2006-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Cash exercise funded by Insider. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 53,702 | $16.72 | $898,020.95 |
DisclosureSEC source: 0001194413-05-000002 · c0001194413d20050310f4f.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 99,451 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Cash exercise funded by Insider. F1 · price: Cash exercise funded by Insider. F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| March 08, 2005 Filed Mar 10, 2005 21:25 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 30,000 | $23.00 | $690,000.00 |
DisclosureSEC source: 0001194413-05-000002 · c0001194413d20050310f4f.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,749 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Cash exercise funded by Insider. F2 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| February 15, 2005 Filed Feb 17, 2005 21:32 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock | 6,197 | $0.00 | $0.00 |
DisclosureSEC source: 0001194414-05-000003 · c0001194413d20050217f4f.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Indirect · By Trust as Beneficiary Disclosed balance after: 162,832 F2 · balance_after: Includes dividend reinvestment shares acquired during the course of the year. Read SEC document |
| January 05, 2005 Filed Jan 7, 2005 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $44.89 | $0.00 |
DisclosureSEC source: 0001194405-05-000003 · c0001194413d20050107f4f.xml · derivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2012-01-05 F1 · derivative.exercise_date: Option becomes exercisable in three equal annual installments, commencing 01/05/2006. Read SEC document |
| January 05, 2005 Filed Jan 7, 2005 21:19 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194405-05-000003 · c0001194413d20050107f4f.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 45,525 Read SEC document |
| February 16, 2004 Filed Feb 18, 2004 21:39 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 6,987 | $0.00 | $0.00 |
DisclosureSEC source: 0001194413-04-000001 · c0001194413d20040218f4f.xml · nonDerivative · entry 4 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 114,033 Read SEC document |
| January 08, 2004 Filed Jan 12, 2004 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantStock Option · Derivative | 50,000 | $0.00 Strike: $35.34 | $0.00 |
DisclosureSEC source: 0001194416-04-000003 · c0001194413d20040112f4f.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2011-01-08 F1 · derivative.exercise_date: Options become exercisable in three equal annual installments, commencing 01/08/2005. Read SEC document |
| January 08, 2004 Filed Jan 12, 2004 20:12 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantCommon Stock (Restricted) | 15,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001194416-04-000003 · c0001194413d20040112f4f.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 107,046 Read SEC document |
| December 31, 2003 Filed Feb 10, 2004 16:04 UTC | CVS HEALTH Corp CVS · Entity 2884 | GrantPhantom Stock Credits · Derivative | 60 | $0.00 Strike: $1.00 | $0.00 |
DisclosureSEC source: 0001194405-04-000003 · c0001194413d20040210f5f.xml · derivative · entry 5 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60 Underlying: Common Stock · 60 shares Expires not disclosed F4 · derivative.exercise_price: Each share credit is equivalent to one share; 1-for-1 conversion. F5 · shares: Reflects 2002 and 2003 year end company match share credits of 33 and 27, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F5 · derivative.exercise_date: Reflects 2002 and 2003 year end company match share credits of 33 and 27, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. F5 · derivative.expiration_date: Reflects 2002 and 2003 year end company match share credits of 33 and 27, respectively, under a non-qualified deferred compensation plan; share credits are payable in cash only, at such time as has been elected by the reporting person. Read SEC document |
| November 12, 2003 Filed Nov 12, 2003 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | SaleCommon Stock | 90,168 | $0.00 | $0.00 |
DisclosureSEC source: 0001194413-03-000002 · c0001194413d20031112f4f.xml · nonDerivative · entry 3 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,496 F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| November 10, 2003 Filed Nov 12, 2003 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 74,000 | $0.00 Strike: $16.72 | $0.00 |
DisclosureSEC source: 0001194413-03-000002 · c0001194413d20031112f4f.xml · derivative · entry 6 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 53,702 Underlying: Common Stock · 74,000 shares Expires 2006-05-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Cash exercise funded by Insider. Read SEC document |
| November 10, 2003 Filed Nov 12, 2003 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionStock Option · Derivative | 16,168 | $0.00 Strike: $15.69 | $0.00 |
DisclosureSEC source: 0001194413-03-000002 · c0001194413d20031112f4f.xml · derivative · entry 5 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 16,168 shares Expires 2005-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · kind: Cash exercise funded by Insider. Read SEC document |
| November 10, 2003 Filed Nov 12, 2003 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 74,000 | $16.72 | $1,237,450.20 |
DisclosureSEC source: 0001194413-03-000002 · c0001194413d20031112f4f.xml · nonDerivative · entry 2 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
| November 10, 2003 Filed Nov 12, 2003 21:40 UTC | CVS HEALTH Corp CVS · Entity 2884 | Exercise / conversionCommon Stock | 16,168 | $15.69 | $253,740.59 |
DisclosureSEC source: 0001194413-03-000002 · c0001194413d20031112f4f.xml · nonDerivative · entry 1 MERLO LARRY J · CIK 0001194413 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,664 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · balance_after: Includes shares acquired pursuant to issuer's Employee Stock Purchase Plan. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.